Cancer Survivorship Research

2 researchers across 1 institution

2 Researchers
1 Institutions
0 Grant PIs
0 High Impact

Cancer survivorship research examines the long-term health and quality of life for individuals who have completed cancer treatment. This field investigates the physical, psychological, social, and economic challenges survivors face, including the management of late effects, recurrence monitoring, and the promotion of healthy lifestyles. Methodologies employed include longitudinal studies, patient-reported outcomes, clinical trials, and health services research. Key sub-areas include understanding and mitigating treatment-related toxicities, addressing mental health needs, and developing interventions to improve functional status and well-being.

In Arkansas, cancer survivorship research is particularly relevant given the state's cancer burden and demographic profile. Understanding the unique needs of diverse survivor populations within Arkansas, including rural communities, is crucial. This work can inform public health strategies aimed at reducing cancer disparities and improving healthcare access for survivors across the state. Furthermore, it contributes to the development of support services and policies that enhance the lives of a growing number of cancer survivors in Arkansas.

This research area draws on expertise from health disparities, behavioral and psychological studies, child and adolescent health, substance abuse treatment, medical education, health research impacts, and public health. Engagement spans multiple institutions within Arkansas, fostering a collaborative approach to addressing the complex needs of cancer survivors.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Rajalakshmi Cheerla UAMS 2 22
Worrell, Shani UAMS 1 1 Faculty

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
1 works in 2031
-52.5% CAGR 2018–2031
Leadership concentration
5.6% held by global top 5 institutions
Fragmented HHI 21
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2031 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 4,481
  2. 2 Memorial Sloan Kettering Cancer Center 3,985
  3. 3 Harvard University 3,622
  4. 4 Dana-Farber Cancer Institute 3,256
  5. 5 University of North Carolina at Chapel Hill 3,006
Browse All 2 Researchers in Directory